🟢 Roivant Sciences is trading 4.2% up today amid a broad tech-led market rebound

Roivant Sciences is trading 4.2% up today at $34.27 amid a broad U.S. equity rebound led by technology stocks.

• The move aligns with a wider market rally, with the S&P 500 up about 1.6% and the Nasdaq up about 2.8%.
• No fresh company-specific news, earnings, FDA decisions, or major analyst calls have been reported for the company so far.
• The price action appears driven by general risk-on sentiment rather than any specific fundamental catalyst.